Literature DB >> 19921857

Variation of keratin 7 expression and other phenotypic characteristics of independent isolates of cadmium transformed human urothelial cells (UROtsa).

Seema Somji1, Xu Dong Zhou, Aaron Mehus, Mary Ann Sens, Scott H Garrett, Krista L Lutz, Jane R Dunlevy, Yun Zheng, Donald A Sens.   

Abstract

This laboratory has shown that a human urothelial cell line (UROtsa) transformed by cadmium (Cd(2+)) produced subcutaneous tumor heterotransplants that resemble human transitional cell carcinoma (TCC). In the present study, additional Cd(2+) transformed cell lines were isolated to determine if independent exposures of the cell line to Cd(2+) would result in malignantly transformed cell lines possessing similar phenotypic properties. Seven independent isolates were isolated and assessed for their doubling times, morphology, ability to heterotransplant subcutaneously and in the peritoneal cavity of nude mice, and for the expression of keratin 7. The 7 cell lines all displayed an epithelial morphology with no evidence of squamous differentiation. Doubling times were variable among the isolates, being significantly reduced or similar to those of the parental cells. All 7 isolates were able to form subcutaneous tumor heterotransplants with a TCC morphology, and all heterotransplants displayed areas of squamous differentiation of the transitional cells. The degree of squamous differentiation varied among the isolates. In contrast to subcutaneous tumor formation, only 1 isolate of the Cd(2+) transformed cells (UTCd#1) was able to effectively colonize multiple sites within the peritoneal cavity. An analysis of keratin 7 expression showed no correlation with squamous differentiation for the subcutaneous heterotransplants generated from the 7 cell lines. Keratin 7 was expressed in 6 of the 7 cell lines and their subcutaneous tumor heterotransplants. Keratin 7 was not expressed in the cell line that was able to form tumors within the peritoneal cavity. These results show that individual isolates of Cd(2+) transformed cells have both similarities and differences in their phenotype.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19921857      PMCID: PMC2822111          DOI: 10.1021/tx900346q

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  29 in total

Review 1.  Cadmium carcinogenesis in review.

Authors:  M P Waalkes
Journal:  J Inorg Biochem       Date:  2000-04       Impact factor: 4.155

2.  Blood cadmium may be associated with bladder carcinogenesis: the Belgian case-control study on bladder cancer.

Authors:  Eliane Kellen; Maurice P Zeegers; Elly Den Hond; Frank Buntinx
Journal:  Cancer Detect Prev       Date:  2007-02-12

3.  Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the M.D. Anderson experience.

Authors:  C J Logothetis; F H Dexeus; C Chong; A Sella; A G Ayala; J Y Ro; S Pilat
Journal:  J Urol       Date:  1989-01       Impact factor: 7.450

4.  Effects of timing and type of tobacco in cigarette-induced bladder cancer.

Authors:  P Vineis; J Esteve; P Hartge; R Hoover; D T Silverman; B Terracini
Journal:  Cancer Res       Date:  1988-07-01       Impact factor: 12.701

5.  Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history.

Authors:  Erik Pasin; David Y Josephson; Anirban P Mitra; Richard J Cote; John P Stein
Journal:  Rev Urol       Date:  2008

Review 6.  Bladder cancer.

Authors:  Daniel A Barocas; Peter E Clark
Journal:  Curr Opin Oncol       Date:  2008-05       Impact factor: 3.645

7.  Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco.

Authors:  J Clavel; S Cordier; L Boccon-Gibod; D Hemon
Journal:  Int J Cancer       Date:  1989-10-15       Impact factor: 7.396

8.  The immortalized UROtsa cell line as a potential cell culture model of human urothelium.

Authors:  M R Rossi; J R Masters; S Park; J H Todd; S H Garrett; M A Sens; S Somji; J Nath; D A Sens
Journal:  Environ Health Perspect       Date:  2001-08       Impact factor: 9.031

Review 9.  Epidemiology of urinary bladder cancer: from tumor development to patient's death.

Authors:  Cristiane Murta-Nascimento; Bernd J Schmitz-Dräger; Maurice P Zeegers; Gunnar Steineck; Manolis Kogevinas; Francisco X Real; Núria Malats
Journal:  World J Urol       Date:  2007-06       Impact factor: 3.661

Review 10.  Adverse health effects of chronic exposure to low-level cadmium in foodstuffs and cigarette smoke.

Authors:  Soisungwan Satarug; Michael R Moore
Journal:  Environ Health Perspect       Date:  2004-07       Impact factor: 9.031

View more
  12 in total

1.  Increased neuron specific enolase expression by urothelial cells exposed to or malignantly transformed by exposure to Cd²⁺ or As³⁺.

Authors:  Maureen Soh; Jane R Dunlevy; Scott H Garrett; Christina Allen; Donald A Sens; Xu Dong Zhou; Mary Ann Sens; Seema Somji
Journal:  Toxicol Lett       Date:  2012-05-14       Impact factor: 4.372

2.  Beclin-1 expression in normal bladder and in Cd2+ and As3+ exposed and transformed human urothelial cells (UROtsa).

Authors:  Jennifer L Larson; Seema Somji; Xu Dong Zhou; Mary Ann Sens; Scott H Garrett; Donald A Sens; Jane R Dunlevy
Journal:  Toxicol Lett       Date:  2010-03-03       Impact factor: 4.372

3.  Kindlin-2 expression in arsenite- and cadmium-transformed bladder cancer cell lines and in archival specimens of human bladder cancer.

Authors:  Sherine Talaat; Seema Somji; Conrad Toni; Scott H Garrett; Xu Dong Zhou; Mary Ann Sens; Donald A Sens
Journal:  Urology       Date:  2011-06       Impact factor: 2.649

4.  SPARC gene expression is repressed in human urothelial cells (UROtsa) exposed to or malignantly transformed by cadmium or arsenite.

Authors:  Jennifer Larson; Tahmina Yasmin; Donald A Sens; Xu Dong Zhou; Mary Ann Sens; Scott H Garrett; Jane R Dunlevy; Ling Cao; Seema Somji
Journal:  Toxicol Lett       Date:  2010-09-16       Impact factor: 4.372

5.  Elevated connexin 43 expression in arsenite-and cadmium-transformed human bladder cancer cells, tumor transplants and selected high grade human bladder cancers.

Authors:  Ruowen Zhang; Liping Wang; Scott H Garrett; Donald A Sens; Jane R Dunlevy; Xu Dong Zhou; Seema Somji
Journal:  Exp Toxicol Pathol       Date:  2016-08-13

Review 6.  Cadmium as a possible cause of bladder cancer: a review of accumulated evidence.

Authors:  Molka Feki-Tounsi; Amel Hamza-Chaffai
Journal:  Environ Sci Pollut Res Int       Date:  2014-06-04       Impact factor: 4.223

7.  ZIP8 expression in human proximal tubule cells, human urothelial cells transformed by Cd+2 and As+3 and in specimens of normal human urothelium and urothelial cancer.

Authors:  Amornpan Ajjimaporn; Tom Botsford; Scott H Garrett; Mary Ann Sens; Xu Dong Zhou; Jane R Dunlevy; Donald A Sens; Seema Somji
Journal:  Cancer Cell Int       Date:  2012-07-04       Impact factor: 5.722

8.  Arsenic, cadmium and neuron specific enolase (ENO2, γ-enolase) expression in breast cancer.

Authors:  Maureen A Soh; Scott H Garrett; Seema Somji; Jane R Dunlevy; Xu Dong Zhou; Mary Ann Sens; Chandra S Bathula; Christina Allen; Donald A Sens
Journal:  Cancer Cell Int       Date:  2011-11-18       Impact factor: 5.722

9.  Prediction of the number of activated genes in multiple independent Cd(+2)- and As(+3)-induced malignant transformations of human urothelial cells (UROtsa).

Authors:  Scott H Garrett; Seema Somji; Donald A Sens; Ke K Zhang
Journal:  PLoS One       Date:  2014-01-22       Impact factor: 3.240

10.  Loss of N-Cadherin Expression in Tumor Transplants Produced From As+3- and Cd+2-Transformed Human Urothelial (UROtsa) Cell Lines.

Authors:  Elizabeth J Sandquist; Seema Somji; Jane R Dunlevy; Scott H Garrett; Xu Dong Zhou; Andrea Slusser-Nore; Donald A Sens
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.